Cargando…

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

OBJECTIVE: Cardiovascular disease (CVD) risk calculators designed for use in the general population do not accurately predict the risk of CVD among patients with rheumatoid arthritis (RA), who are at increased risk of CVD. The process of developing risk prediction models involves numerous issues. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crowson, Cynthia S., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M., Gabriel, Sherine E., Semb, Anne Grete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363942/ https://www.ncbi.nlm.nih.gov/pubmed/28334012 http://dx.doi.org/10.1371/journal.pone.0174656

Ejemplares similares

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
por: Crowson, Cynthia S., et al.
Publicado: (2017)

A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis - SURF-RA
por: Semb, Anne Grete, et al.
Publicado: (2022)

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit()
por: Semb, Anne Grete, et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Kerola, Anne Mirjam, et al.
Publicado: (2021)

Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models
por: Wibetoe, Grunde, et al.
Publicado: (2020)

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients
por: Roelsgaard, Ida K, et al.
Publicado: (2020)

Hyperuricemia and Incident Cardiovascular Disease and Noncardiac Vascular Events in Patients with Rheumatoid Arthritis
por: Kuo, Daniel, et al.
Publicado: (2014)

EULAR Task Force Recommendations on Annual Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis: An Audit of the Success of Implementation in a Rheumatology Outpatient Clinic
por: Ikdahl, Eirik, et al.
Publicado: (2015)

All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study
por: Kerola, Anne M, et al.
Publicado: (2022)

Serum Samples That Have Been Stored Long-Term (>10 Years) Can Be Used as a Suitable Data Source for Developing Cardiovascular Risk Prediction Models in Large Observational Rheumatoid Arthritis Cohorts
por: Arts, Elke E. A., et al.
Publicado: (2014)

Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trøndelag Health Study (HUNT)
por: Gulati, Agnete Malm, et al.
Publicado: (2018)

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
por: Semb, Anne Grete, et al.
Publicado: (2021)

Increased Incidence of Atrial Fibrillation in Patients with Rheumatoid Arthritis
por: Bacani, A. Kirstin, et al.
Publicado: (2015)

Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases
por: Rollefstad, Silvia, et al.
Publicado: (2015)

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
por: Choy, Ernest, et al.
Publicado: (2014)

The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial
por: Roelsgaard, Ida Kristiane, et al.
Publicado: (2017)

The effect of brief versus individually tailored dietary advice on change in diet, lipids and blood pressure in patients with inflammatory joint disease
por: Fagerhøi, Maria Grorud, et al.
Publicado: (2018)

Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?
por: Wing, Simon, et al.
Publicado: (2015)

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018)

Determinants of Disability in Rheumatoid Arthritis: A Community-Based Cohort Study
por: Krause, Megan L., et al.
Publicado: (2015)

Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management
por: Dessein, Patrick H., et al.
Publicado: (2015)

A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case–control study
por: Ghawi, Husam, et al.
Publicado: (2015)

Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases
por: Svanteson, Mona, et al.
Publicado: (2017)

Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study
por: Os, Hanna A, et al.
Publicado: (2020)

Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
por: Montes, Daniel, et al.
Publicado: (2023)

A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis
por: Davis, John M, et al.
Publicado: (2012)

Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity
por: Davis, John M, et al.
Publicado: (2013)

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab
por: Provan, Sella Aarrestad, et al.
Publicado: (2015)

How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study
por: Roelsgaard, Ida Kristiane, et al.
Publicado: (2020)

Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study
por: Ikdahl, Eirik, et al.
Publicado: (2016)

Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study
por: Ikdahl, Eirik, et al.
Publicado: (2015)

Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases
por: Svanteson, Mona, et al.
Publicado: (2019)

Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis
por: Adlan, Ahmed M., et al.
Publicado: (2017)

Translating patient education theory into practice: Developing material to address the cardiovascular education needs of people with rheumatoid arthritis
por: John, Holly, et al.
Publicado: (2011)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Cardiovascular disease risk profiles in inflammatory joint disease entities
por: Wibetoe, Grunde, et al.
Publicado: (2017)

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured
por: Navarro-Millán, Iris, et al.
Publicado: (2022)

Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009
por: Olson, Timothy C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gvrgk95os2vnc7up3t2o6fdc9n